Reducing preterm birth risks in foetal surgery, KOVE Medical secures €1.7 million
Zurich-based MedTech startup KOVE Medical has closed a €1.7 million (CHF 1.6 million) to develop an implantable medical device designed to reduce the risk of preterm birth following foetal surgery, with the fresh capital set to support the company as it progresses towards First-in-Human studies. The
<p>Zurich-based MedTech startup KOVE Medical has closed a €1.7 million (CHF 1.6 million) to develop an implantable medical device designed to reduce the risk of preterm birth following foetal surgery, with the fresh capital set to support the company as it progresses towards First-in-Human studies. The</p>